Legend Biotech Corporation Q1 Loss Rises

Legend Biotech Corporation (LEGN) released Loss for its first quarter of -$100.92 million

The company's earnings came in at -$100.92 million, or -$0.27 per share. This compares with -$59.79 million, or -$0.16 per share, last year.

Excluding items, Legend Biotech Corporation reported adjusted earnings of -$27.00 million or -$0.07 per share for the period.

The company's revenue for the period rose 107.5% to $195.05 million from $93.99 million last year.

Legend Biotech Corporation earnings at a glance (GAAP) :

-Earnings: -$100.92 Mln. vs. -$59.79 Mln. last year.
-EPS: -$0.27 vs. -$0.16 last year.
-Revenue: $195.05 Mln vs. $93.99 Mln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com